cGMP Method Transfer
Move an established procedure to a receiving laboratory after its method package and readiness gaps are understood.
Build analytical methods that survive the entire product lifecycle
Analytical method development services should be phase-appropriate, scientifically defensible, and practical for the laboratory that will execute the procedure. Poor analytical methods rarely fail during development—they fail during transfer, validation, routine QC testing, or FDA inspection. A method that appears acceptable in the laboratory can become a source of OOS investigations, repeat testing, manufacturing delays, and regulatory questions if robustness and controls are not engineered from the beginning. Triclinic Labs develops and troubleshoots cGMP analytical methods for manufacturing laboratories and long-term lifecycle performance. Using current ICH expectations, risk-based experimental design, and decades of pharmaceutical experience, we build methods that withstand validation, technology transfer, commercial manufacturing, and regulatory scrutiny rather than simply generating acceptable validation statistics.
We develop methods with the end user in mind—QC analysts, manufacturing, and regulators—not just the development laboratory.
Content scientifically reviewed by Andy Gilkison, Ph.D., Senior Director, Method Development at Triclinic Labs · Updated 9/1/2026
When method development, validation, or verification is the right starting point
- No suitable procedure exists for the material, matrix, quality attribute, or decision.
- An existing research method needs optimization before controlled cGMP use.
- A noncompendial quantitative or limit test method must be developed and validated for a drug substance, excipient, intermediate, formulation, finished product, contaminant, or solid-state mixture for which no applicable compendial method exists.
- A compendial procedure must be verified for the proposed laboratory, instrument, sample matrix, and intended use.
- A solid-state method must distinguish polymorphs, hydrates, solvates, crystalline and amorphous content, or phase mixtures in a representative product matrix.
How Triclinic develops, validates, and verifies analytical methods
Work begins with the analytical target profile or intended-use statement: what attribute must be measured, in which material and matrix, over what range, with what decision limit, and under which quality status. Development then addresses the failure modes most likely to undermine routine use, including selectivity, sample-preparation variability, matrix interference, instability, form conversion, inadequate sensitivity, calibration design, and unrealistic system suitability.
Validation demonstrates that a noncompendial procedure performs suitably for its intended use. The selected characteristics may include specificity, accuracy, precision, intermediate precision, linearity, range, detection limit, quantitation limit, robustness, system suitability, and sample or solution stability. Verification is narrower: it confirms that a compendial procedure performs suitably in the proposed laboratory and matrix without implying that the full procedure has been revalidated.
For solid-state methods, the design may also need to control particle size, packing density, preferred orientation, form conversion, excipient interference, reference standards, instrument geometry, and the choice between univariate and multivariate calibration.
Regulatory and quality framework reflected in the work
Regulated method work should be scoped to the intended use of the procedure, the sample matrix, the decision the data must support, and the quality-system status of the work. For cGMP work, laboratory controls, specifications, sampling, testing, release decisions, and laboratory records must be planned so that the resulting data package can be reviewed, repeated, and defended.
- Align the validation design with ICH Q2(R2), FDA method-validation guidance, and the analytical procedure lifecycle principles in ICH Q14.
- Define the validation characteristics that actually apply to the procedure: specificity/selectivity, accuracy, precision, intermediate precision, detection limit, quantitation limit, linearity, range, robustness, system suitability, and solution or sample stability where relevant.
- For cGMP execution, ensure laboratory controls, written procedures, representative samples, specifications, and records are addressed before regulated data generation.
- Document method limitations and conditions of use; do not imply release suitability until the method status, specification, and quality records support that use.
- For compendial methods or alternative procedures, distinguish validation from verification or method adaptation.
Typical deliverables
- Method target profile or intended-use summary.
- Development report summarizing experiments, parameters, controls, failure modes, and selected method conditions.
- Validation protocol with method category, validation characteristics, acceptance criteria, samples, standards, and execution plan.
- Validated method procedure or controlled draft ready for client quality-system adoption.
- Validation report with raw data, calculations, chromatograms, spectra, diffractograms, images, tables, deviations, and conclusions.
- Recommendations for method maintenance, transfer, release testing, or supplemental robustness work.
Figures and Examples
Related services and next lifecycle steps
cGMP Release Testing Services
Execute a validated, verified, or transferred procedure against defined specifications under controlled cGMP documentation.
Analytical Capabilities by Instrument
Select an appropriate platform for the material, matrix, sensitivity, specificity, and evidence requirements.
cGMP Analytical Services
Connect method work to regulated spectroscopy, diffraction, chromatography, particle, thermal, morphology, and NMR services.
Common questions
Common questionsWhat is the difference between analytical method validation and verification?
Validation demonstrates that a noncompendial procedure is fit for its intended use. Verification confirms that a compendial procedure can achieve suitable performance in the proposed laboratory and sample matrix. The required verification work depends on the procedure, matrix, risk, and available evidence.
Which characteristics are evaluated during method validation?
Depending on the intended use, validation may evaluate specificity or selectivity, accuracy, repeatability, intermediate precision, linearity, range, detection limit, quantitation limit, robustness, system suitability, and sample or solution stability.
Can solid-state analytical methods be validated?
Yes. Solid-state validation may require controls for form specificity, matrix effects, sample preparation, particle properties, standards, instrument configuration, calibration design, and data processing.
Can a research method be converted into a cGMP method?
Often, but the procedure must first be assessed for intended use, matrix suitability, controls, system suitability, acceptance criteria, reference materials, record requirements, robustness, and the validation or verification evidence needed for controlled use.
How are validation acceptance criteria established?
Acceptance criteria should follow from intended use, product and process risk, specification needs, prior method performance, matrix behavior, reference materials, and applicable regulatory or compendial expectations.
What deliverables can the project include?
Deliverables may include an analytical target profile, development report, controlled procedure, validation or verification protocol, execution data, deviations, final report, method limitations, and recommendations for transfer or routine use.
Discuss cGMP method development and validation requirements
Send the method, matrix, intended use, specification, sample type, quality status, and whether the work supports development, validation, transfer, release, stability, or investigation support.
